Output Biosciences
Teaching Generative AI the Language of Biology
Output Biosciences is pioneering Biologically-Aware Generative AI to finally understand complex biological systems. Our new generative AI architecture can handle the extremely long, nonlinear, fragmented, and high dimensional data of biological systems. We are building Large Biological Models that can generate breakthrough medicines and transform the way we diagnose, treat and prevent disease.
Jobs at Output Biosciences
Active Founders
Mirella Mashiach
Mirella is a former big pharma executive and biotech investor. She was the Managing Director of the $200M corporate venture biotech fund at Teva Pharmaceuticals and its VP of BD and Strategy. Prior to that, Mirella was an attorney at Dentons, where she focused on intellectual property and corporate and commercial deals in life sciences.
Adi Mashiach, MD
Adi is a repeat founder of AI-driven biotech startups, former physician, and computational systems biology researcher. He was the founder of Nyxoah (NASDAQ:NYXH), a leading sleep apnea therapy based on a neurotech and adaptive learning platform. He founded Innovea (acquired), a medical imaging startup focused on diffusion-based computer vision. His innovative research in machine learning and nonlinear dynamics predicted cancer therapy responses from cell images. Adi holds over 85 US patents.
